Max Healthcare Institute: 7 Stock Signals Investors Are Watching Right Now
- September 18, 2026
- Posted by: Harsh Piplani
- Category: Market
Max Healthcare Institute CMP Rs 1,037.0. 52W range Rs 903-1,222. Mcap Rs 1.01 lakh crore. PE 69.05 vs sector 66.97.
Quick Answer
Max Healthcare stock signals right now span an earnings picture, a shareholding pattern where promoter holding has been essentially flat around 23.71%-23.74% for five straight quarters, and a technical setup where the stock trades well off its 52-week low of Rs 903. Debt to equity stands at 0.32, and valuation sits at a P/E of 69.05 against a sector average of 66.97. Corporate developments in the hospitals and healthcare services space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.
Max Healthcare stock signals are unusually layered right now, with the company trading at Rs 1,037.0, 15.1% below its 52-week high of Rs 1,222 and 14.8% above its 52-week low of Rs 903. Max Healthcare Institute is a well tracked name in the hospitals and healthcare services space, and no single headline captures where the stock stands today.
This article does not make a buy, hold or sell call on Max Healthcare Institute. It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.
Click Here – Get Free Investment Predictions
Max Healthcare Institute Stock at a Glance
Before going through each of the seven Max Healthcare stock signals in detail, the snapshot below sets the starting point on price, valuation and balance sheet strength.
| Metric | Value |
|---|---|
| Max Healthcare Institute CMP | Rs 1,037.0 (NSE, 18 Sep 2026) |
| 52-Week High | Rs 1,222 (17 August 2026) |
| 52-Week Low | Rs 903 (6 April 2026) |
| Market Capitalisation | Rs 1.01 lakh crore |
| P/E Ratio | 69.05 (Sector P/E 66.97) |
| P/B Ratio | 9.36 |
| Debt to Equity | 0.32 |
| Return on Equity | 13.42% |
1. Earnings Trend at Max Healthcare Institute
Max Healthcare Institute closed the latest full year with revenue of Rs 8,536 crore versus Rs 7,184 crore a year earlier, while net profit moved to Rs 1,442 crore from Rs 1,076 crore, a change of 34.1% on the year. The most recent quarter added Rs 2,407 crore in revenue, a change of 16.6% year on year, against Rs 323 crore in net profit versus Rs 308 crore a year earlier.
operating margin has ranged between 25.9% and 30.5% over the last five quarters, and net profit was up close to 5% year on year in the June 2026 quarter, extending full year FY26 growth of over 34%. This is the first of the seven Max Healthcare stock signals worth tracking closely into the next results.
2. FII Holding in Max Healthcare Institute
FII holding in Max Healthcare Institute has declined from 54.76% to 41.78% across the last reported quarters (Jun ’25 54.76%, Sep ’25 51.8%, Dec ’25 50.55%, Mar ’26 45.39%, Jun ’26 41.78%). Domestic institutions have moved from 17.42% to 29.96% over the same stretch.
Reading FII and DII holding together alongside the price action gives a fuller picture than either figure alone, since foreign and domestic flows do not always move in the same direction around a stock’s price swings.
3. Promoter Holding in Max Healthcare Institute
Promoter holding in Max Healthcare Institute has been essentially flat around 23.71%-23.74% for five straight quarters, based on the last reported quarters (Jun ’25 23.74%, Sep ’25 23.74%, Dec ’25 23.72%, Mar ’26 23.71%, Jun ’26 23.71%).
A stable or rising promoter stake is typically read as a sign that controlling shareholders have not used any recent price weakness to pare their position, though it is only one data point among the seven here.
4. Debt Position at Max Healthcare Institute
Max Healthcare Institute’s debt to equity ratio stands at 0.32, versus 0.24 in FY25 a year earlier, one of the balance sheet metrics worth tracking alongside the earnings trend above. A lower or stable ratio generally gives more room to fund growth without leaning further on external borrowing, while a rising one is worth watching for its effect on finance costs.
This debt signal should be read alongside the valuation and corporate development signals below rather than in isolation, since capital raising plans can shift the picture from one quarter to the next.
5. Valuation of Max Healthcare Institute Shares
At the current price, Max Healthcare Institute trades at a price to earnings ratio of 69.05, a premium of close to 3.1% versus the sector average of 66.97. The price to book ratio stands at 9.36.
Whether that premium looks justified depends on the earnings trend from Signal 1 continuing, and it is one of the clearer places where the seven signals can pull in different directions at the same time.
6. Technical Trend on the Max Healthcare Institute Chart
The stock closed around Rs 1,037.0, below both its 50-day moving average of about Rs 1,050 and its 200-day moving average of about Rs 1,038, a classic sign of a sustained downtrend. The 14-day RSI reads close to 58, in neutral territory. The MACD line sits above its signal line, a bullish momentum bias on the daily chart.
Over the past year the stock is currently 15.1% below its 52-week high of Rs 1,222 and 14.8% above its 52-week low of Rs 903. A sustained move back above the 50-day average would be an early technical sign of stabilisation.
7. Corporate Developments at Max Healthcare Institute
Max Healthcare’s subsidiary Kalinga Hospital completed a rights issue allotting 50,21,212 equity shares to Max Healthcare for Rs 87.87 crore, closing on 7 September 2026, while separately disclosing NCLT petitions filed by BRS Capital against Kalinga Hospital, with the next hearing scheduled for 28 September 2026; the company has also outlined plans to invest over Rs 1,000 crore in a new 450-bed Pune hospital.
Check the Univest Screener for live fundamentals
What These Max Healthcare stock signals Mean Together
None of these seven signals on its own settles the debate on Max Healthcare Institute. Reading them as a set, rather than picking out any single one, is the more balanced way to approach the stock right now. The earnings trend, shareholding pattern, balance sheet position, valuation, technical setup and corporate developments each add one piece of the picture, and they do not all point the same way at the same time.
Investors weighing Max Healthcare Institute would do well to watch the next quarterly results for a read on where margins and profit are heading, alongside the next shareholding pattern update for any shift in FII or promoter positioning. Reading these Max Healthcare stock signals together, rather than in isolation, remains the more balanced approach. As with any single stock, price movements can be volatile and past trends do not guarantee future performance.
Also Read: HDFC Bank: 7 Stock Signals Investors Are Watching Right Now
Conclusion
Max Healthcare Institute currently sits at the intersection of several moving parts, from earnings and shareholding to valuation and chart trend, and that is exactly what the seven signals above are meant to surface. This article does not recommend buying, holding or selling Max Healthcare Institute shares, and readers should form their own view based on their own research and risk appetite.
Download the Univest iOS App or Univest Android App to track Max Healthcare Institute live price and more such signal based stock research.
Disclaimer: Data and figures in this article are sourced from publicly available information and the company’s exchange filings. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Max Healthcare Institute Stock Signals
Why is Max Healthcare Institute share price where it is right now?
Ans. Max Healthcare Institute shares are trading 15.1% below their 52-week high of Rs 1,222 and 14.8% above their 52-week low of Rs 903, shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.
What is Max Healthcare Institute’s current FII holding?
Ans. FII holding in Max Healthcare Institute stood at 41.78% as of the most recent quarter.
Is Max Healthcare Institute’s debt position a concern right now?
Ans. The debt to equity ratio stands at 0.32, versus 0.24 in FY25 a year earlier.
What is the promoter holding in Max Healthcare Institute?
Ans. Promoter holding in Max Healthcare Institute stood at 23.71% as of the most recent quarter.
Is Max Healthcare Institute expensive compared to its sector?
Ans. Max Healthcare Institute trades at a price to earnings ratio of 69.05 against a sector average of 66.97.
What recent corporate developments are relevant to Max Healthcare Institute?
Ans. Max Healthcare’s subsidiary Kalinga Hospital completed a rights issue allotting 50,21,212 equity shares to Max Healthcare for Rs 87.87 crore, closing on 7 September 2026, while separately disclosing NCLT petitions filed by BRS Capital against Kalinga Hospital, with the next hearing scheduled for 28 September 2026; the company has also outlined plans to invest over Rs 1,000 crore in a new 450-bed Pune hospital.
What do the technical charts suggest about Max Healthcare Institute right now?
Ans. The stock is trading below both its 50-day moving average of about Rs 1,050 and its 200-day moving average of about Rs 1,038, a classic sign of a sustained downtrend, with a 14-day RSI near 58 and its MACD line above its signal line, a bullish momentum bias.
Should investors buy Max Healthcare Institute shares at current levels?
Ans. This article does not offer a buy, hold or sell recommendation. It lays out seven Max Healthcare stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.
